Huimin Wang - 08 Nov 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, Japan & Intercontinental
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
08 Nov 2021
Net transactions value
-$620,014
Form type
4
Filing time
08 Nov 2021, 17:10:28 UTC
Previous filing
08 Oct 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $138,176 +6,350 +6.5% $21.76 104,377 08 Nov 2021 Direct F1
transaction EW Common Stock Sale $758,190 -6,350 -6.1% $119.40 98,027 08 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -6,350 -25% $0.000000 19,050 08 Nov 2021 Common Stock 6,350 $21.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person